Status:
COMPLETED
Ectopic Pregnancy Biomarkers
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Bill and Melinda Gates Foundation
National Institutes of Health (NIH)
Conditions:
Ectopic Pregnancy
Eligibility:
FEMALE
Brief Summary
In an attempt to simplify the diagnosis of ectopic pregnancy, the researchers will investigate the presence of specific molecular markers of ectopic pregnancy. The quantification of these (and other p...
Eligibility Criteria
Inclusion
- Reproductive-aged women
- Currently pregnant based on serum human chorionic gonadotropin level
- Present for care for pregnancy due to vaginal bleeding and/or pelvic cramping
- Final diagnosis of one of the following:
- Live intrauterine pregnancy through 14 weeks, diagnosed by ultrasound demonstrating fetal heart motion
- Diagnosed ectopic pregnancy
- Ultrasound confirmation of a nonviable gestation (less 14 weeks) such as an anembryonic gestation or a fetal demise
Exclusion
- None
Key Trial Info
Start Date :
June 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
1306 Patients enrolled
Trial Details
Trial ID
NCT00194168
Start Date
June 1 2000
End Date
November 1 2013
Last Update
August 16 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California Women's and Children's Hospital
Los Angeles, California, United States, 90033
2
University of Miami
Miami, Florida, United States, 33101
3
University of Pennsylvania Reproductive Research Unit
Philadelphia, Pennsylvania, United States, 19104